Mortality in schizophrenia.

Auquier, Pascal, Lançon, Christophe, Rouillon, Frédéric, Lader, Malcolm, Holmes, Catriona·2006·Pharmacoepidemiology and Drug Safety
DOI 10.1002/pds.1325

Cited by (249)

Items 201–249 of 249

  1. Schizophrenia
    Kaitlin E. Browman, Min Zhang, Gerard B. Fox, Lynne E. Rueter · 2008 · CRC Press eBooks
  2. Schizophrenia is associated with severe consequences
    Kalyani Rajalingham · 2023 · Psiquiatría Biológica
  3. Effects of gestational haloperidol exposure on mRNA expressions related to glutamate and GABA receptors in offspring
    Hiroshi Kumon, Yuta Yoshino, Yu Funahashi, Shinichiro Ochi, Jun‐ichi Iga, Shuichi Ueno · 2023 · IBRO Neuroscience Reports
  4. Determinants/Predictors of QT Abnormalities in Patients on Psychotropic Medications in a Nigerian Tertiary Hospital
    Opeyemi Ezekiel Ojo, Ebenezer Adekunle Ajayi, Akande Oladimeji Ajayi, Joseph Olusesan Fadare, Samuel Ayokunle Dada, Olatunji Bukola Olaoye · 2024 · Cardiovascular Toxicology
  5. The Cancer Screening Disparity among Women With Schizophrenia by Co-occurring Chronic Physical Illness Status: A Nationwide Cohort Study in Taiwan
    Ching-Ching Lin, Chih-Chun Chuang, Chenyang Wang, Shou‐Hsia Cheng · 2025 · Schizophrenia Bulletin
  6. Thyroid gland and cerebella lesions: New risk factors for sudden cardiac death in schizophrenia?
    Fulvio Alexandre Scorza, Ésper A. Cavalheiro, Marly de Albuquerque, Juliana de Albuquerque, Roberta Monterazzo Cysneiros, Vera Cristina Terra, Ricardo Mário Arida · 2010 · Medical Hypotheses
  7. Existing and emerging smoking cessation options for people with schizophrenia spectrum disorders
    Pasquale Caponnetto, Jennifer DiPiazza, Maria Salvina Signorelli, Marilena Giovanna Maglia, Riccardo Polosa · 2018 · Journal of Addictive Diseases
  8. Preclinical and Clinical Investigation of Antipsychotic Polypharmacy: What Is the Evidence?
    Dimitrios Kontis, Eirini Theochari · 2012 · Springer eBooks
  9. Psychotic Disorders and Bipolar Affective Disorder
    RANGASWAMY THARA, Padmavati Ramachandran · 2009
  10. Suicide and mortality related to mental disorder in three Swedish cohorts
    Dag Tidemalm · 2010 · Figshare
  11. Cold weather and risk of sudden cardiac death in schizophrenia: finding a new Achilles' heel?
    Fulvio Alexandre Scorza, Roberta Monterazzo Cysneiros, Ésper A. Cavalheiro, Ricardo Mário Arida, Wagner F. Gattaz · 2008 · Brazilian Journal of Psychiatry
  12. Prospective cohort studies of disability pension and mortality in a Swedish county
    Nadine E. Karlsson · 2007 · Figshare
  13. Omega-3 consumption and sudden unexpected death in schizophrenia: a “fish” a day keeps heart disease away
    Fulvio Alexandre Scorza, Carla Alessandra Scorza, Ana Claudia FIORINI, Jair de Jesus Mari, Leandro Freitas, Josef Finsterer · 2019 · Psychopharmacology
  14. Modulation of prefrontal glutamatergic transmission and "atypicality" of antipsychotic drugs
    Åsa Konradsson‐Geuken · 2007 · Figshare
  15. Metabolic Effect of Atypical Antipsychotics
    Rami A Mortada, Justin Moore, Jean M. Dostou · 2010 · Kansas Journal of Medicine
  16. Suicide risk in schizophrenia – a follow-up study after 20 years
    Gian Lippi, DJ Smit, JC Jordaan, Johannes Lodewikus Roos · 2009 · South African Medical Journal
  17. Cannabis, schizophrenia and other psychoses : longitudinal studies on Swedish conscripts
    Edison Manrique-Garcia · 2014 · Figshare
  18. A Comparison Between the UK and a Malaysian Setting of Antipsychotic Prescribing on Forensic Wards Using Prescribing Observatory for Mental Health-UK Standards
    Dominic Johnson · 2012 · The Malaysian journal of psychiatry
  19. Biomarkers of Suicide Risk in Psychosis
    Andreas Carlborg · 2009 · Figshare
  20. Regional disease characteristics and comorbidities of patients with schizophrenia in the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): Findings from an international large simple trial
    John Michael Kane, Wolfgang Fleischhacker, Francesca M. Kolitsopoulos, Onur N. Karayal, Jamie L. Geier, CYNTHIA O. SIU, Robert Reynolds, Gerald A. Faich, Brian L. Strom · 2012 · Open Journal of Psychiatry
  21. Douleur en santé mentale, sujet d’avenir
    Françoise Radat, Eric Serra · 2009 · Douleurs Évaluation - Diagnostic - Traitement
  22. Schizophrenia: if death occurs without warning, what we should propose for the near future?
    Fulvio Alexandre Scorza, Carlos A. Zarate · 2014 · Archives of Clinical Psychiatry (São Paulo)
  23. Korrelate von Familienklima und Erziehungsstil in Familien von psychotisch ersterkrankten Adoleszenten
    Georg G. von Polier · 2010
  24. Psychiatrists' opinions on somatic health in patients with schizophrenia - results of a Polish nationwide study.
    Andrzej Kiejna, Andrzej Czernikiewicz · 2010
  25. Sudden death with clozapine and refractory schizophrenia: a case study
    Frédéric Aknouche, Gérald Quatrehomme, Emilie Guibert, Matthieu Eyraud, Robert Buti, Kévin Fargeot, Pascal Kintz · 2012
  26. Orthomolecular Treatment Response
    Raymond J. Pataracchia · 2010
  27. Refractory schizophrenia Esquizofrenia refratária
    Hélio Elkis, Herbert Y. Meltzer · 2007
  28. Original Research Medication adherence and glycemic control in patients with psychotic disorders in the Veterans Affairs healthcare system
    Leigh Anne Nelson, Maqual R. Graham, Cameron C. Lindsey, Rafia S. Rasu · 2011 · Dialnet (Universidad de la Rioja)
  29. Antipsychotic Polypharmacy in Czech Republic and in Ukraine
    Віктор Павлович Самохвалов, O. Samokhvalova, В.А. Вербенко, G.N. Verbenko · 2012 · Springer eBooks
  30. Suicide Risk in Schizophrenia, a 20 Year Cohort Study, Part 1: Outcome and associated social factors
    Gian Lippi, D J Smit, Joyce C. Jordaan, J L Roos · 2009 · South African Journal of Psychiatry
  31. Candidate gene and microRNA expression studies of schizophrenia
    Shannon Bruse · 2008 · Rutgers University Community Repository (Rutgers University)
  32. 조현병 환자에서 항정신병약물 병용요법의 최근 동향
    장진구, 노대영, 김찬형 · 2013
  33. "Transtornos mentais graves na comunidade: um estudo em São Paulo"
    Lílian Ribeiro Caldas Ratto · 2005
  34. Cold weather and risk of sudden cardiac death in schizophrenia: finding a new Achilles' heel? Baixas temperaturas e risco de morte súbita cardíaca na esquizofrenia: desvendando um novo calcanhar de Aquiles?
    Fulvio Alexandre Scorza, Roberta Monterazzo Cysneiros, Ésper A. Cavalheiro, Ricardo Mário Arida, Wagner F. Gattaz · 2008 · DOAJ (DOAJ: Directory of Open Access Journals)
  35. schizophrenics in Stockholm Schizophrenia and crime. A longitudinal follow-up of 644
    Pelle G. Lindqvist, Peter Alle­beck · 2011
  36. Gastrointestinal adverse effects of clozapine therapy
    Klinika Psychiatrii Wieku Podeszłego i Zaburzeń Psychotycznych, Centralny Szpital Kliniczny w Łodzi, Adam Wysokiński · 2015 · Psychiatria i Psychologia Kliniczna
  37. Impact of Chronic Medical and Neuropsychiatric Illnesses on Quality of Life and Life Expectancy among Patients at the University of Port Harcourt Teaching Hospital (UPTH)
    Aborlo Kennedy Nkporbu · 2020 · IntechOpen eBooks
  38. Improving physical health in patients with severe mental illness
    Shin-Min Lee, Ding‐Lieh Liao · 2020 · Taiwanese Journal of Psychiatry
  39. The assessment of psychopathological symptoms and the course of schizophrenia depending on gender, duration of the disease, somatic comorbidity and suicide attempts
    Marta Broniarczyk-Czarniak, Agata Orzechowska, Piotr Gałecki · 2020 · Pharmacotherapy in Psychiatry and Neurology
  40. De la relation à l’alliance thérapeutique auprès d’adolescents et jeunes adultes présentant un risque de transition psychotique : le point de vue de professionnels de santé mentale. Une étude exploratoire
    Vanessa de Blaine, Jean‐Manuel Morvillers · 2021 · Recherche en soins infirmiers
  41. Estudio de utilización de psicofármacos en usuarios de la Policlínica del Hospital Vilardebó con diagnóstico de esquizofrenia (años 2006 y 2016)
    2021 · Revista de Psiquiatría del uruguay
  42. Schizophrenia and Gender
    Ana Isabel Cano-Baena, Laura García-Ayala, Marta Zubía-Martín, Eric P. Zorrilla, Ana González-Pinto Arrillaga · 2019 · Springer eBooks
  43. Current awareness: Pharmacoepidemiology and drug safety
    2007 · Pharmacoepidemiology and Drug Safety
  44. Predictors of mortality in severe mental illness inpatients: A 10-year prospective cohort study
    Luísa Monteiro Burin, Cristiane Bauermann Leitão, Shanna Luiza de Castro, Giulio Bertollo Alexandrino, Bruno Perosa Carniel, Neusa Sica da Rocha · 2026 · Journal of Affective Disorders
  45. Caractérisation des perturbations métaboliques induites par les antipsychotiques dans un modèle murin : approches par la résonance magnétique
    Florent Auger · 2014
  46. Corrélats anatomiques et fonctionnels de la réponse clinique au traitement par Stimulation Magnétique Transcrânienne répétée (rTMS) chez des patients atteints de schizophrénie avec des hallucinations auditives résistantes
    Fanny Thomas · 2020 · theses.fr (ABES)
  47. Sex and Gender Differences in Psychosis
    Beatriz Isabel Molina Cañas, María Guadalupe Obregón Sánchez, Oihane Mentxaka Solozabal · 2026 · Springer eBooks
  48. EXAMINATION OF THE DISCRIMINATIVE STIMULUS AND CROSS-TOLERANCE INDUCING PROPERTIES OF N-DESMETHYLCLOZAPINE IN C57BL/6 MICE.
    Jason M. Wiebelhaus · 2009 · VCU Scholars Compass (Virginia Commonwealth University)
  49. A COMPARISON OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC CLOZAPINE AND THE GLUTAMATE AGONIST N-METHYL D-ASPARTATE IN C57BL/6 MICE.
    Sarah A. Vunck · 2009 · VCU Scholars Compass (Virginia Commonwealth University)